- Report
- September 2026
- 190 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- September 2025
- 150 Pages
Global
From €4013EUR$4,450USD£3,441GBP
- Report
- March 2026
- 320 Pages
Global
From €3743EUR$4,150USD£3,209GBP
- Report
- September 2026
- 182 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 186 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 193 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 193 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- May 2026
- 139 Pages
Global
From €2705EUR$2,999USD£2,319GBP
€3606EUR$3,999USD£3,093GBP
- Report
- September 2026
- 182 Pages
Global
From €5276EUR$5,850USD£4,524GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- September 2026
- 180 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- May 2026
- 524 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- February 2026
- 250 Pages
Global
From €4049EUR$4,490USD£3,472GBP
- Report
- May 2026
- 400 Pages
Global
From €4463EUR$4,949USD£3,827GBP
- Report
- April 2026
- 143 Pages
Global
From €2705EUR$2,999USD£2,319GBP
€3606EUR$3,999USD£3,093GBP

Inflammatory Bowel Disease (IBD) is a group of chronic disorders that cause inflammation of the gastrointestinal tract. It is a major area of focus within the field of Allergy and Immunology, as it is believed that the immune system plays a role in the development and progression of IBD. Symptoms of IBD can include abdominal pain, diarrhea, rectal bleeding, and weight loss. Treatment options include medications, lifestyle changes, and surgery.
IBD is a growing area of research and development, with many companies developing new treatments and therapies. Companies such as AbbVie, Janssen, and Takeda are researching and developing new drugs to treat IBD. Other companies such as Enterome, Immuron, and Seres Therapeutics are developing microbiome-based therapies to treat IBD. Additionally, companies such as Medtronic and Boston Scientific are developing medical devices to treat IBD. Show Less Read more